Abstracts

149 – Time-to-Rebound Measurements in ATI Trials With bNAb Intervention Are Confounded by Autologous NAbs

Background Many HIV cure trials use time-to-rebound during an analytic treatment interruption (ATI) as a primary outcome measurement. In a previously described ATI study with no intervention, the fraction of replication-competent outgrowth viruses neutralized by contemporaneous autologous neutralizing antibodies (aNAbs) prior to ART interruption correlated with time to rebound. Therefore, aNAbs may also contribute to…

148 – Bispecific Antibody VRC07/PGT121 Protects Against High-Dose Intravenous SHIV-BG505 Challenge

Background Non-human primate (NHP) and human clinical studies highlight the utility of broadly neutralizing antibodies (bNAbs) for immunoprophylaxis against HIV-1. Passively delivered bNAbs protect against viral strains susceptible to antibody-mediated neutralization.  To protect against HIV-1 strains resistant to individual antibodies, endeavors to improve bNAb breadth are required.  A key strategy to enhance the neutralization breadth…

139 – RhCMV Expands CCR5 Memory CD4 T Cells and Increases Acute-Phase Seeding of SIV DNA in the Gut Mucosa

Background Cytomegalovirus (CMV) is a prevalent beta-herpesvirus that persists asymptomatically in immunocompetent hosts. More than 90% of people with HIV are co-infected with CMV. During long-term ART, HIV-1/CMV-coinfection is associated with inflammatory-related co-morbidities and persistence of the HIV-1 reservoir, yet the precise degree to which CMV contributes to these pathologies remains unclear. Methods We utilized…

1308 – An AI-Powered Preventive Intervention for Stigma and Suicidal Ideation in HIV Self-Management

Background Self-harm and suicidal ideation are significant health concerns among people with or vulnerable to HIV (PWH), who frequently experience stigma and related mental health challenges such as stress, anxiety, and depression. The AI-powered MARVIN chatbot provides HIV self-management-related knowledge and assists with medication adherence (antiretroviral therapy and pre-exposure prophylaxis). It also provides a safe…

1312 – Impact Analysis and Machine Learning Forecasts of HIV Viral Load Suppression in 21 African Countries

Background Viral load suppression (VLS) is crucial for controlling HIV transmission and improving health outcomes in people living with HIV. While PEPFAR-supported programs have made substantial progress in improving VLS, innovative approaches are needed to sustain and enhance VLS in resource-limited settings. This analysis integrates machine learning and the difference-in-difference (DiD) method to forecast future…

1288 – DoxyPrEP Impact on the Microbiome of Men Who Have Sex With Men and Transgender Women on HIV PrEP

Background Doxycycline pre-exposure prophylaxis (doxyPrEP) has shown potential in preventing bacterial sexually transmitted infections (STIs) in gay, bisexual and other men who have sex with men (GBM). However, its impact on the microbiome is unknown. This study assessed rectal microbiome changes over 48 weeks in participants on HIV PrEP enrolled in a doxyPrEP trial. Methods…